• The Beachbody Company outlined a shift to a multi-channel model following the disbanding of its multi-level marketing structure in December 2024, aiming to remove a 40%-55% commission burden on sales and renewals.
• The presentation highlighted 10 consecutive quarters of positive adjusted EBITDA totaling USD 69.8 million, operating income of USD 17.4 million in 2025, and free cash flow in 2025.
• Retail expansion plans include selling Shakeology in Sprouts starting in late Q2 2026, then rolling out nationally in Vitamin Shoppe stores in fall 2026, alongside a smaller, lower-priced 7-serve format for retail, direct-to-consumer, and Amazon.
• New P90X and Insanity-branded supplements and energy drinks are slated for retail distribution in 2H 2026, with sales into grocery, drug, mass, club, and convenience channels.
• Cost and balance sheet actions cited include headcount reduced to under 300 from over 1,000 since 2022, selling and marketing expense down to 34.6% of revenue in Q1 2026 from 53.5% in 2023, and debt refinanced to USD 25 million from USD 50 million with the interest rate cut to 14.8% from 28%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Beachbody Company Inc. published the original content used to generate this news brief on May 18, 2026, and is solely responsible for the information contained therein.